Learn more about DBS therapy and how you can refer your patients suffering from movement disorders.
How DBS works
Deep Brain Stimulation (DBS) therapy uses mild electrical pulses to help manage the symptoms of movement disorders such as Parkinson’s disease, dystonia, or essential tremor.
The system consists of thin wires called 'leads' implanted in specific areas of the brain, connected to a stimulator placed under the skin in the chest. Once turned on, the device sends targeted impulses to help correct abnormal brain activity, improving symptoms like tremor, stiffness, and slowness.

Watch the videos to learn more
Time for a more precise approach to movement disorders
Deep Brain Stimulation (DBS) helps control symptoms when medication is no longer enough.4,5,6

The Vercise Genus™ Battery Portfolio offers four small, contoured IPGs (similar to pacemakers) designed to deliver targeted brain stimulation while maximising patient comfort, convenience, and MRI compatibility.*

With Image Guided DBS technology, the neurosurgeon can precisely place the leads in specific areas of the brain. Advanced imaging facilitates accurate planning and programming, ensuring optimal placement and fine-tuning of the system.

Once activated, the DBS system delivers controlled electrical impulses that regulate the brain’s signaling pathways. By modulating abnormal nerve activity, DBS can significantly improve motor symptoms, providing patients with greater stability and control.4,5,6
Vercise GenusTM Deep Brain Stimulation System
Easily customise therapy to match each patient’s needs with the Vercise Genus DBS system.

4 thin, contoured ImageReady MR-Conditional rechargeable and non-rechargeable IPGs.
The most therapy options including Semi-bipolar and Anodic stimulation.**
Personalise therapy with Image Guided Programming.
Image Guided Programming
See stimulation to personalise therapy in each patient’s specific anatomy. Image Guided Programming makes delivering directional stimulation easier and more efficient, with a 56%¹ reduction in programming time.

VerciseTM Neural Navigator 5 Software with Image Guided Programming
Vercise Neural Navigator 5 Software makes it easier and more efficient to personalise your patients’ DBS journey.


DBS Handbook
Contact and support
*The Vercise Genus™ DBS System, Vercise Genus Mixed System with M8 Adapter, Vercise Gevia™ DBS System, and Vercise™ DBS Lead-only system (before Stimulator is implanted) provide safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under specific conditions defined in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems.
**Information for competitive devices excerpted from literature published by Medtronic (M982261A015 Rev A, M017563C002 Rev A, M939241A051 Rev A, M927170A073 Rev A, M017562C002 Rev A) and Abbott (ARTEN600150429 - B, ARTEN600102238 - A) Schüpbach, Michael & Chabardes, Stephan & Matthies, Cordula & Pollo, Claudio & Steigerwald, Frank & Timmermann, Lars & Vandewalle, Veerle & Volkmann, Jens & Schuurman, P.. (2017). Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders. 32. 10.1002/mds.27096.
REFERENCES:
1. Lange F, 2021, Front. Neurol. doi: 10.3389/FNEUR.2021.785529/BIBTEX
2. Torres V et al. Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson’s disease. npj Parkinsons Dis. 10, 29 (2024).
3. Aldred J., et al., 2023, MDS 2023 e-poster.
4. Okun et al., Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: An open-label randomized, controlled trial. Lancet Neurology. 2012. 11(2): 140-149.
5. Timmerman et al., Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomized, prospective, multicenter, open-label study. Lancet Neurology. 2015. 14: 693-701.
6. Krack et al., Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's disease.N. Engl J Med. 2003. 349: 1925-34.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.